UniSa - IRIS Institutional Research Information System

MASARONE, Mario
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.215
EU - Europa 823
AS - Asia 598
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 4
SA - Sud America 1
Totale 4.646
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.200
CN - Cina 352
IT - Italia 293
UA - Ucraina 173
IE - Irlanda 120
TR - Turchia 106
VN - Vietnam 106
DE - Germania 77
SE - Svezia 54
FI - Finlandia 27
FR - Francia 26
KR - Corea 19
GB - Regno Unito 17
CA - Canada 12
RU - Federazione Russa 12
CZ - Repubblica Ceca 7
IN - India 7
DK - Danimarca 6
EU - Europa 5
NL - Olanda 4
AU - Australia 3
ES - Italia 2
HK - Hong Kong 2
HN - Honduras 2
MY - Malesia 2
RO - Romania 2
TW - Taiwan 2
BR - Brasile 1
JP - Giappone 1
LV - Lettonia 1
MD - Moldavia 1
MX - Messico 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
Totale 4.646
Salva come PNG Salva come JPEG
Città #
Ann Arbor 778
Chandler 360
Princeton 344
Woodbridge 334
Jacksonville 263
Houston 172
Ashburn 132
Dublin 118
Dong Ket 106
Izmir 106
Beijing 105
Wilmington 102
Nanjing 72
Andover 63
Pellezzano 44
Boardman 41
Naples 31
Fairfield 27
Salerno 27
Redwood City 26
Changsha 23
Hebei 23
Norwalk 23
Shenyang 22
Washington 18
Jinan 17
Dearborn 16
Nanchang 16
Jiaxing 12
Tianjin 12
Jinju 10
Nürnberg 10
Seattle 10
Maletto 9
Milan 9
Pontecagnano 9
Cambridge 8
Haikou 8
Los Angeles 8
Ottawa 8
San Diego 8
Düsseldorf 7
Fisciano 7
Falls Church 6
Guangzhou 6
Rome 6
San Mango Piemonte 6
Zhengzhou 6
Lappeenranta 5
Mestre 5
Brno 4
Kunming 4
Munich 4
Napoli 4
Pompei 4
Pune 4
Redmond 4
Saint Petersburg 4
Simi Valley 4
Bolzano 3
Caiazzo 3
Daejeon 3
Falkenstein 3
Fuzhou 3
Issum 3
Lanzhou 3
Latina 3
London 3
New York 3
San Giorgio A Cremano 3
Venezia 3
Weimar 3
Aachen 2
Amsterdam 2
Assago 2
Cosenza 2
Edmonton 2
Esslingen am Neckar 2
Hanover 2
Hefei 2
Indiana 2
Kirribilli 2
Kuala Lumpur 2
Menlo Park 2
Mercato San Severino 2
Miami 2
Monte San Giovanni Campano 2
Ningbo 2
Parete 2
Taoyuan District 2
Tappahannock 2
Telese 2
Verona 2
Walnut 2
Xian 2
Auckland 1
Aversa 1
Bari 1
Battipaglia 1
Bengaluru 1
Totale 3.710
Salva come PNG Salva come JPEG
Nome #
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 115
Coeliac disease and C virus-related chronic hepatitis: a non association 105
HIGH PREVALENCE OF HEPATITIS C (HCV) INFECTION AND FAVORABLE PROGNOSIS IN PRIMARY HEPATIC LYMPHOMA (PHL) 101
Association between non-alcoholic fatty liver disease, insulin resistance and Helicobacter pylori. 91
Efficacy and safety of new direct antiviral agents in HCV infected patients with Diffuse Large B Cell Non-Hodgkin Lymphoma 89
Alcoholic Hepatitis: Pathogenesis, Diagnosis and Treatment 86
Sustained virological response by direct antiviral agents in HCV leads to an early and significant improvement of liver fibrosis 86
Diaphragmatic motility assessment in COPD exacerbation, early detection of Non-Invasive Mechanical Ventilation failure: a pilot study 85
The effect of antiviral therapy on hepatitis C virus-related thrombocytopenia: a case report. 84
Occult hepatitis B virus infection in patients with non-Hodgkin lymphoma: the need for early diagnosis in anti-Hbc positive patients 83
"Non alcoholic fatty liver disease and eNOS dysfunction in humans" 80
A Long-term Treatment with Silybin in Patients with Non-alcoholic Steatohepatitis Stimulates Catalase Activity in Human Endothelial Cells 79
Liver biopsy in type 2 diabetes mellitus: Steatohepatitis represents the sole feature of liver damage 78
Alcoholic Liver Disease and Hepatitis C Chronic Infection 74
Epidemiology and Natural History of Alcoholic Liver Disease 73
Corrigendum to "Antiviral therapy after complete response to chemotherapy could be efficacious in HCV-positive non-Hodgkin's lymphoma" [J Hepatol 49 (2008) 557-563] (DOI:10.1016/j.jhep.2008.06.025) 73
FN 44 HEPATIC RETINOL BINDING PROTEIN 4 (RBP-4) LEVELS ARE SIGNIFICANTLY RELATED TO THE STEATOHEPATITIS GRADE (COMPROMISSION) BUT NOT WITH HCV INFECTION 72
[629] THE INFLUENCE OF OBESITY AND DIABETES ON CLINICAL AND THERAPEUTICAL OUTCOME IN HCV RELATED CHRONIC HEPATITIS: AN ITALIAN NATIONWIDE SURVEY STUDY (PROBE GROUP) 71
Etiology of newly-diagnosed cases of chronic liver disease in Southern Italy: Results of a prospective multicentric study 71
Lung ultrasound for diagnosis of pneumonia in emergency department 70
Genetic predictors of response to treatment of chronic hepatitis C virus infection in patients from southern Italy 70
Pharmacotherapy of alcoholic liver disease in clinical practice 69
Antiviral therapy: Why does it fail in HCV-related chronic hepatitis? 69
Management of the HBV reactivation in isolated HBcAb positive patients affected with Non Hodgkin Lymphoma. 67
The epidemiology of non-alcoholic fatty liver disease and its connection with cardiovascular disease: Role of endothelial dysfunction 67
Inferior vena cava collapsibility to guide fluid removal in slow continuous ultrafiltration: A pilot study 66
Lispro insulin in people with non-alcoholic liver cirrhosis and type 2 diabetes mellitus 65
Erratum to: HBV and HCV infection in type 2 diabetes mellitus: a survey in three diabetes units in different Italian areas 63
Impact of telaprevir in HCV patients with cirrhosis and RVR: Real-life data from boceprevir or telaprevir based “triple therapy” experience in southern Italy 63
Interference of diet on liver histology and on the response to interferon therapy in patients with HCV-related chronic liver disease 61
Focus on emerging drugs for the treatment of patients with non-alcoholic fatty liver disease 61
Clinical expression of insulin resistance in hepatitis C and B virus-related chronic hepatitis: differences and similarities. 60
Rapid Virological Response Represents the Highest Prediction Factor of Response to Antiviral Treatment in HCV-Related Chronic Hepatitis: a Multicenter Retrospective Study. 59
The role of bright liver echo pattern on ultrasound B-mode examination in the diagnosis of liver steatosis. 58
Steatohepatitis is associated with diabetes and fibrosis in genotype 1b HCV-related chronic liver disease 58
507 The role of HBV occult infection in patients with non-hodgkin lymphoma: Prevalence and treatment options with nucleotide analogues 58
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis 58
442 TNF-alpha and IL-10 genetic polymorphisms influence the natural history and the response to antiviral therapy in HCV related chronic hepatitis 56
Antiviral therapy after complete response to chemotherapy could be efficacious in HCV-positive non-Hodgkin's lymphoma. 55
P. 253 Rapid virological response in genotype 1b patients treated with peginterferon plus ribavirin: evidence for a significant sustained virological response (SVR) after 24 weeks of therapy in peg-interferon-alpha-2a treated patients 55
Helicobacter pylori infection but not small intestinal bacterial overgrowth may play a pathogenic role in rosacea 54
Hepatitis C virus carriers with persistently normal ALT levels: biological peculiarities and update of the natural history of liver disease at 10 years. 53
HBV and HCV infection in type 2 diabetes mellitus: a survey in three diabetes units in different Italian areas 53
Vascular endothelial dysfunction in inflammatory bowel diseases: Pharmacological and nonpharmacological targets 53
Non Alcoholic Fatty Liver: Epidemiology and Natural History 52
HCV antiviral therapy in injection drug users: difficult to treat or easy to cure? 52
Role of Oxidative Stress in Pathophysiology of Nonalcoholic Fatty Liver Disease 51
Insulin resistance and liver steatosis in chronic hepatitis C infection genotype 3 50
Endocan Serum Levels in Patients with Non-Alcoholic Fatty Liver Disease with or without Type 2 Diabetes Mellitus: A Pilot Study 50
Untargeted metabolomics as a diagnostic tool in NAFLD: discrimination of steatosis, steatohepatitis and cirrhosis 50
The diagnostic conundrum in non-alcoholic fatty liver disease 49
Impact of telaprevir in HCV patients with cirrhosis and RVR: real-life data from Boceprevir or Telaprevir based "triple therapy" experience in southern Italy 47
Evaluation of allelic frequency and genetic risk score of non-alcoholic fatty liver disease in a population of Southern Italy 46
Indirect markers of non-alcoholic fatty liver disease: Another piece of the puzzle? 44
Incidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: Interim evaluations from the PITER network 44
HCV-genotype 3h, a difficult-to-diagnose sub-genotype in the DAA era 44
The impact of diet on liver fibrosis and on response to interferon therapy in patients with HCV-related chronic hepatitis. 43
Interleukin-10 - 1082 GG polymorphism influences the occurrence and the clinical characteristics of hepatitis C virus infection. 42
Pressure support ventilation vs Continuous positive airway pressure for treating of acute cardiogenic pulmonary edema: A pilot study 42
Hepatitis C screening during SARS-CoV-2 testing or vaccination. Experience in an area of Southern Italy in the province of Salerno 42
Screening, Linkage to Care and Treatment of Hepatitis C Infection in Primary Care Setting in the South of Italy 41
Characterisation of asymptomatic patients and efficacy of preventive measures for SARS-CoV-2 infection in a large population of Southern Italy: a cohort study 39
Viral hepatitis: Milestones, unresolved issues, and future goals 38
Lactate determination in pleural and abdominal effusions: a quick diagnostic marker of exudate-a pilot study 37
VIROLOGICAL PATTERNS OF HCV PATIENTS WITH FAILURE TO INTERFERON-FREE REGIMENS 37
Role of bisphenol A as environmental factor in the promotion of non-alcoholic fatty liver disease: in vitro and clinical study 36
Adiponectin in hepatology 36
Real-life effectiveness and safety of Glecaprevir/Pibrentasvir in HCV infected patients with chronic kidney disease 36
Qualitative and Quantitative Evaluation of Dietary Intake in Patients with Non-Alcoholic Steatohepatitis 34
Chitosan-coated liposomes loaded with butyric acid demonstrate anticancer and anti-inflammatory activity in human hepatoma HepG2 cells 34
Real‐Life Efficacy and Safety of Glecaprevir/Pibrentasvir in HCV Infected Patients with Chronic Kidney Disease 34
THU-304-Modeling NAFLD-related disease progression among the PITER SVR12 cohort 34
Assessing the impact of COVID-19 on the management of patients with liver diseases: A national survey by the Italian association for the study of the Liver 33
THU0289 PERSISTENCE OF CIRCULATING CRYOGLOBULINS AND RELATED SYMPTOMS AFTER HEPATITIS C VIRUS ERADICATION IN PATIENTS WITH MIXED CRYOGLOBULIN SYNDROME 32
Chemical effect of bisphenol a on non-alcoholic fatty liver disease 31
Hepatitis C virus infection in jail: Difficult-to-reach, not to-treat. Results of a point-of-care screening and treatment program 31
Real-life glecaprevir/pibrentasvir in a large cohort of patients with hepatitis C virus infection: The MISTRAL Study 30
NAFLD and extra-hepatic comorbidities: Current evidence on a multi-organ metabolic syndrome 30
THU-122-Sofosbuvir/velpatasvir ± ribavirin for retreatment of patients with chronic hepatitis C virus infection and advanced fibrosis failing to a previous DAA combination regimen 29
HCV point-of-care screening program and treatment options for people who use drugs in a metropolitan area of Southern Italy 29
Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV 25
Alcoholic Consumption of Young Italians During the SARS-CoV-2 Pandemic 24
Hepatitis C Virus Infection and Non-Hepatocellular Malignancies in the DAA Era: A Systematic Review and Meta-Analysis 23
Associated screening for HCV and SARS-Cov2 infection in an urban area of Southern Italy: a cohort study 23
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 22
Inflammation and Fibrogenesis in MAFLD: Role of the Hepatic Immune System 22
Nutrigenomics and nutrigenetics in metabolic-(Dysfunction) associated fatty liver disease: Novel insights and future perspectives 20
Evaluation of the Effect Derived from Silybin with Vitamin D and Vitamin E Administration on Clinical, Metabolic, Endothelial Dysfunction, Oxidative Stress Parameters, and Serological Worsening Markers in Nonalcoholic Fatty Liver Disease Patients 18
The role of resveratrol in liver disease: A comprehensive review from in vitro to clinical trials 17
The role of fructose in non-alcoholic steatohepatitis: Old relationship and new insights 17
Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO) 17
A prospective study of DAA Effectiveness and Relapse Risk in HCV Cryoglobulinemic Vasculitis by the Italian PITER Cohort 17
Solving the gap between HCV detection and treatment in prison. HCV-RNA testing and treatment in a cohort of new arriving convicts in Southern Italy 16
PNPLA3, TM6SF2, and MBOAT7 Influence on Nutraceutical Therapy Response for Non-alcoholic Fatty Liver Disease: A Randomized Controlled Trial 13
Optimizing systemic therapy for advanced hepatocellular carcinoma: the key role of liver function 13
Italian association for the study of the liver position statement on SARS-CoV2 vaccination 12
Management of liver disease in Italy after one year of the SARS-CoV-2 pandemic: A web-based survey 10
Profiling the risk of hepatocellular carcinoma after long-term HCV eradication in patients with liver cirrhosis in the PITER cohort 9
Glecaprevir/Pibrentasvir is safe and effective in Italian patients with chronic hepatitis C aged 75 years or older: A multicentre study 8
Screening for hepatitis C at the time of the pandemic: Need to adjust the shot 5
Totale 4.877
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.071
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.071
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019146 0 0 0 0 0 0 0 0 0 0 121 25
2019/2020665 198 7 64 19 29 20 50 16 26 122 83 31
2020/2021562 28 35 44 19 58 38 65 13 39 12 81 130
2021/2022609 6 6 9 7 10 10 22 31 83 82 80 263
2022/2023918 102 72 54 110 99 189 3 67 135 5 60 22
2023/2024371 35 49 36 24 39 100 26 32 9 19 2 0
Totale 4.885